GSA Capital Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Buy |
+12,305
| New | +$339K | 0.02% | 1183 |
|
|
2025
Q1 | – | Sell |
-5,944
| Closed | -$247K | – | 1925 |
|
|
2024
Q4 | $247K | Buy |
5,944
+302
| +5% | +$12.5K | 0.02% | 1316 |
|
|
2024
Q3 | $377K | Buy |
+5,642
| New | +$377K | 0.03% | 1108 |
|
|
2024
Q1 | – | Sell |
-2,703
| Closed | -$269K | – | 1840 |
|
|
2023
Q4 | $269K | Buy |
+2,703
| New | +$269K | 0.02% | 1172 |
|
|
2022
Q4 | – | Sell |
-2,149
| Closed | -$254K | – | 1731 |
|
|
2022
Q3 | $254K | Buy |
+2,149
| New | +$254K | 0.03% | 1041 |
|
|
2022
Q2 | – | Sell |
-1,868
| Closed | -$322K | – | 1658 |
|
|
2022
Q1 | $322K | Buy |
+1,868
| New | +$322K | 0.04% | 843 |
|
|
2021
Q2 | – | Sell |
-3,078
| Closed | -$403K | – | 1502 |
|
|
2021
Q1 | $403K | Sell |
3,078
-1,609
| -34% | -$211K | 0.07% | 468 |
|
|
2020
Q4 | $490K | Buy |
+4,687
| New | +$490K | 0.08% | 436 |
|
|
2019
Q3 | – | Sell |
-18,062
| Closed | -$264K | – | 1589 |
|
|
2019
Q2 | $264K | Buy |
+18,062
| New | +$264K | 0.03% | 1084 |
|